Plasma ACE2 species are differentially altered in COVID‐19 patients

Studies are needed to identify useful biomarkers to assess the severity and prognosis of COVID‐19 disease, caused by severe acute respiratory syndrome coronavirus (SARS‐CoV‐2) virus. Here, we examine the levels of various plasma species of the SARS‐CoV‐2 host receptor, the angiotensin‐converting enz...

Descripción completa

Detalles Bibliográficos
Autores principales: García‐Ayllón, María‐Salud, Moreno‐Pérez, Oscar, García‐Arriaza, Juan, Ramos‐Rincón, José‐Manuel, Cortés‐Gómez, María‐Ángeles, Brinkmalm, Gunnar, Andrés, Mariano, León‐Ramírez, José‐Manuel, Boix, Vicente, Gil, Joan, Zetterberg, Henrik, Esteban, Mariano, Merino, Esperanza, Sáez‐Valero, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441911/
https://www.ncbi.nlm.nih.gov/pubmed/34191346
http://dx.doi.org/10.1096/fj.202100051R

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441911/
https://www.ncbi.nlm.nih.gov/pubmed/34191346
http://dx.doi.org/10.1096/fj.202100051R

Ejemplares similares